Litigation Details for Vanda Pharmaceuticals Inc. v. Roxane Laboratories Inc. (D. Del. 2014)
✉ Email this page to a colleague
Vanda Pharmaceuticals Inc. v. Roxane Laboratories Inc. (D. Del. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-06-16 |
| Court | District Court, D. Delaware | Date Terminated | 2016-08-25 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 8,586,610 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Roxane Laboratories Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Vanda Pharmaceuticals Inc. v. Roxane Laboratories Inc. (D. Del. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-06-16 | 1 | more of claims of Vanda’s U.S. Patent No. 8,586,610 (“the ’610 patent”), which relates to the field of… 8 PageID #: 43 IV. THE PATENT-IN-SUIT – U.S. PATENT NO. 8,586,610 13. The allegations…610 patent, or any extensions thereof. Roxane will infringe one or more claims of the ’610 patent under…United States Patent and Trademark Office (“USPTO”) duly and legally issued the ’610 patent on November… ’610 patent is attached to this Complaint as Exhibit A. 15. The ’610 patent covers | External link to document | |
| 2014-06-16 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,586,610 B2. (snb) (Entered:…2014 25 August 2016 1:14-cv-00757 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
